Indeed, studies on anti-encephalitis caused by JEV infection showed that targeting CCR2 and other inflammatory cytokines/chemokines could all improve the occurrence of encephalitic disease progression [40,59]. This evidence concerns the gene CCR2 and viral encephalitis.